Researcher
Christel Fontaine
- Keywords:Medicine
- Disciplines:Cancer therapy
Affiliations
- Medical Oncology (Department)
Member
From1 Jun 2010 → Today - Laboratory for Medical and Molecular Oncology (Research group)
Member
From1 Jan 2010 → Today - Clinical sciences (Department)
Member
From5 Jan 2021 → Today - Clinical sciences (Department)
Member
From1 May 2012 → 20 Oct 2022
Publications
1 - 10 of 41
- Phase II Trial Assessing the Repeatability and Tumor Uptake of [68Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast Carcinoma(2024)
Authors: Odrade Gondry, Vicky Caveliers, Catarina Xavier, Marian Vanhoeij, Guy Verfaillie, Christel Fontaine, Katrien Glorieus, Jacques De Grève, S Joris, Ine Luyten, et al.
Pages: 178-184 - Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)(2023)
Authors: Odrade Gondry, Catarina Xavier, Laurens Raes, Johannes Heemskerk, Nick Devoogdt, Hendrik Everaert, K Breckpot, Q Lecocq, Lore Decoster, Christel Fontaine, et al.
Pages: 1378-1384 - Towards precision pain medicine for pain after cancer(2023)
Authors: Jo Nijs, Astrid Lahousse, César Fernández-de-Las-Peñas, Pascal Madeleine, Christel Fontaine, Tomohiko Nishigami, Christine Desmedt, Marian Vanhoeij, Kenza Mostaqim, Antonio I Cuesta-Vargas, et al.
Pages: 611-621 - Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19(2022)
Authors: Tatjana Geukens, M. Brandão, A Laenen, Joelle Collignon, C Van Marcke, Ingrid Louviaux, Wim Demey, S Van Wambeke, D Schrijvers, S LECOMTE, et al.
- Lung Restriction in Patients With Breast Cancer After Hypofractionated and Conventional Radiation Therapy(2022)
Authors: Sylvia Verbanck, Hilde Van Parijs, Daniël Schuermans, Vincent Vinh-Hung, Guy Storme, Christel Fontaine, Mark De Ridder, Dirk Verellen, Eef Vanderhelst, Shane Hanon
Pages: 561-569 - ROSALINE(2022)
Authors: Elisa Agostinetto, Guilherme Nader-Marta, Marianne Paesmans, Lieveke Ameye, Isabelle Veys, Laurence Buisseret, Patrick Neven, Donatienne Taylor, Christel Fontaine, Francois P Duhoux, et al.
Pages: 2381-2392 - Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis(2022)
Authors: Lisa A. Carey, Delphine Loirat, Kevin Punie, Aditya Bardia, Véronique Diéras, Florence Dalenc, Jennifer Robinson Diamond, Christel Fontaine, Grace Wang, Hope S. Rugo, et al.
Pages: 1-72 - Efficacy of a Flat Low Dose of Nivolumab in Advanced Cancer(2022)
Authors: S Joris, Christel Fontaine, Lore Decoster, Jacques Vanderauwera, Kris Thielemans, Wim Waelput, Jacques De Grève
Pages: 1433-1437 - Gini's mean difference and the long-term prognostic value of nodal quanta classes after pre-operative chemotherapy in advanced breast cancer(2022)
Authors: Vincent Vinh-Hung, Hilde Van Parijs, Olena Gorobets, Christel Fontaine, Nam P Nguyen, Bhumsuk Keam, Dung Minh Nguyen, Mark De Ridder
- Cardiopulmonary-related patient-reported outcomes in a randomized clinical trial of radiation therapy for breast cancer.(2021)
Authors: Hilde Van Parijs, Vincent Vinh-Hung, Christel Fontaine, Guy Storme, Claire Verschraegen, Dung M. Nguyen, Nele Adriaenssens, Nam P Nguyen, Olena Gorobets, Mark De Ridder